Magnetic Resonance and Scintigraphy 99mTc-MIBI in the Diagnosis and
Monitoring of Therapy in Multiple Myeloma
Nekula J.1, Mysliveček M.2, Bačovský J.3, Horák D.1, Koranda P.2, Kamínek M.2, Ščudla V.3, Vytřasová M.3
Radiologická klinika FN a LF UP, Olomouc1 přednosta prof. MUDr. J. Nekula, CSc. Klinika nukleární medicíny FN a LF UP, Olomouc2 přednosta doc. MUDr. M. Mysliveček, PhD. III. interní klinika FN a LF UP, Olomouc3 přednosta prof. MUDr. V. Ščudla, CSc. |
|
Summary:
The authors compare the importance of scintigraphic examination bymeans of 99mTc-MIBI and MR
for the examination of spine and pelvis in multiple myeloma (MM). A total of 39 patients were
examined with three weeks at a maximum, on the average during 10 days by both methods. The
demonstration of pathological changes in new forms of the disease was virtually the same in both
methods; there was a complete agreement in monoclonal gammapathies of undetermined significance
– negative results in all cases. The advantage of scintigraphy is in the examination of the whole
body and examination of extramedullar lesions, but its disadvantage lays in the fact that it cannot
disclose epidural propagation of MM and compression of vertebrae. On the other hand it is faster
in the diagnosis of remission of the disease, since pathological changes last for longer period of time
when examined by MR. It is difficult to compare the proportion of focal and diffusion changes in
individual methods, since scintigraphy cannot disclose foci smaller than 10 mm.
The authors are of the opinion that the diagnostic algorithm should first employ scintigraphy for
introductory examination and apply MR according to the scintigraphy results – obviously with the
exception of cases, where compression in the spine canal is suspected.
Key words:
multiple myeloma – 99mTc-MIBI scintigraphy – magnetic resonance
|